The Current Ratio as of September 2024 (TTM) for Aileron Therapeutics, Inc. (ALRN) is 4.69

According to Aileron Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.69. This represents a change of -4.02% compared to the average of 4.89 of the last 4 quarters.

Aileron Therapeutics, Inc. (ALRN) Historical Current Ratio (quarterly & annually)

How has ALRN Current Ratio performed in the past?

The mean historical Current Ratio of Aileron Therapeutics, Inc. over the last ten years is 5.83. The current 4.69 Current Ratio has changed 7.95% with respect to the historical average. Over the past ten years (40 quarters), ALRN's Current Ratio was at its highest in in the March 2021 quarter at 20.93. The Current Ratio was at its lowest in in the September 2014 quarter at 0.

Aileron Therapeutics, Inc. (ALRN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Aileron Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aileron Therapeutics, Inc. (ALRN) Average Current Ratio

How has ALRN Current Ratio performed in the past?

The current Current Ratio of Aileron Therapeutics, Inc. (ALRN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aileron Therapeutics, Inc. (ALRN) Current Ratio vs. Peers

How is ALRN’s Current Ratio compared to its peers?

Aileron Therapeutics, Inc.’s Current Ratio is less than Applied Molecular Transport Inc. (4.99), greater than Catalyst Biosciences, Inc. (0), greater than Bio-Path Holdings, Inc. (1.67), greater than Benitec Biopharma Inc. (4.18), less than Artelo Biosciences, Inc. (14.58), greater than Histogen Inc. (4.05), greater than Curis, Inc. (1.78), greater than Timber Pharmaceuticals, Inc. (0.50), greater than Evelo Biosciences, Inc. (0.48), less than Aptinyx Inc. (5.12), less than Magenta Therapeutics, Inc. (14.64), greater than ABVC BioPharma, Inc. (0.33), less than Neoleukin Therapeutics, Inc. (15.33), greater than CytomX Therapeutics, Inc. (1.00), greater than Assembly Biosciences, Inc. (2.74), less than Instil Bio, Inc. (15.06), less than Nuvation Bio Inc. (11.49), greater than First Wave BioPharma, Inc. (1.21), greater than Salarius Pharmaceuticals, Inc. (2.98), less than SAB Biotherapeutics, Inc. (5.24), greater than Vaccinex, Inc. (0.42), greater than GeoVax Labs, Inc. (0.60),

Build a custom stock screener for Aileron Therapeutics, Inc. (ALRN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aileron Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aileron Therapeutics, Inc. (ALRN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aileron Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.